An overview of once‐weekly glucagon‐like peptide‐1 receptor agonists—available efficacy and safety data and perspectives for the futureSten Madsbad, Jens J. Holst, Meena Asmar et al.|Diabetes Obesity and Metabolism|2011Cited by 201